Abbott, which produces the pioneering FreeStyle Libre system, has announced it is donating thousands of the world's leading sensor-based glucose monitoring technology to hospitals.

This will allow frontline healthcare workers to monitor peoples’ glucose status better while in the hospital and also remotely once they have been discharged.

Up to 6,500 FreeStyle Libre sensors are being handed over which will equip as many as 3,250 at-risk people who are living with diabetes for a month, so they can go home sooner and stay connected with their healthcare professional post-discharge, helping them to stay well.

Dr Pratik Choudhary, senior lecturer and consultant in diabetes, Kings College Hospital, London and co-chair of the Diabetes Technology Network (DTN ), said: “Recent data shows that people with diabetes have an elevated risk of adverse outcomes with COVID-19, which is also linked to their glucose control.

“We are really pleased that Abbott has agreed to our request to help us support patients with diabetes who are admitted to hospital by donating FreeStyle Libre sensors.

“During the COVID-19 pandemic, we have been constantly looking for ways to limit unnecessary exposure between ourselves and patients, especially people with diabetes. The use of the FreeStyle Libre system will facilitate frequent monitoring of glucose for those who need it to control their blood glucose. It also allows us to view patient data remotely, supporting timely discharge with safe and effective remote follow-up.”

Neil Harris, general manager of Abbott's diabetes care business in the UK and Ireland, added: “Providing frontline healthcare professionals and patients with technology and equipment is critical in the fight against COVID-19.

“We’re delighted to make FreeStyle Libre sensors available for hospitalised people living with diabetes, which will help frontline healthcare workers to monitor and manage the glucose levels of these patients better and, at the same time, help limit COVID-19 exposure, helping to keep people safe.”